Skip Navigation


NDT Advance Access originally published online on May 21, 2007
Nephrology Dialysis Transplantation 2007 22(8):2400-2401; doi:10.1093/ndt/gfm278
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/8/2400    most recent
gfm278v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zar, T.
Right arrow Articles by Palmisano, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zar, T.
Right arrow Articles by Palmisano, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
(Section Editor: G. H. Neild)

Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with systemic lupus erythematosus (SLE) and lupus nephritis

Tausif Zar, Wilner Samson and Joseph Palmisano

Division of Nephrology, Department of Medicine, University of Connecticut

Correspondence and offprint requests to: Dr Tausif Zar, 263 Farmington Avenue, Farmington, Connecticut 06032, USA. Email: zarjr73@yahoo.com

Keywords: Reversible posterior leukoencephalopathy syndrome; RPLS; Hypertensive encephalopathy; lupus nephritis-leukoencephalopathy syndrome

The first 10% of the full text of this article appears below.

A 20-year-old Asian woman with a well-established history of systematic lupus erythematosus (SLE) and lupus nephritis (WHO stage IVB) presented to the emergency department with generalized arthralgia and headaches. Her current medications included cellcept 1000 mg daily and prednisone 30 . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?